Form 4: Eastman Chemical Co Director, James J. O'Brien, Reports Acquisition of Restricted Stock

Director James J. O'Brien reports acquisition of 1,252 shares of Eastman Chemical Co restricted stock on May 2, 2024, as part of the director's annual Restricted Stock Award.

Summary

• On May 2, 2024, James J. O'Brien, a director of Eastman Chemical Co, acquired 1,252 shares of common stock.
• These shares were received as a restricted stock award, with restrictions lapsing on May 2, 2025, contingent upon continued service as a director.
• The acquisition was a direct transaction.
• Following the transaction, O'Brien directly owns 3,803 shares and indirectly owns 1,022 shares through a revocable trust.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a standard transaction related to director compensation, which aligns the director's interests with shareholders.

Positives

• The acquisition of restricted stock by a director can be seen as a positive sign, aligning the director's interests with those of the shareholders.

Industry Context

This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It provides transparency into the equity holdings of company directors.

Comparison to Industry Standards

• Director compensation packages often include restricted stock awards to incentivize long-term performance and align director interests with shareholder value, similar to practices at companies like Dow and BASF.
• The vesting schedule of one year is relatively standard, comparable to vesting schedules seen at companies like LyondellBasell.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders by aligning the director's interests with the company's long-term performance.

Key Dates